Not yet recruiting
A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer
I4T-MC-JVDU - ClinicalTrials.gov - NCT04557384
The purpose of this study in participants with advanced cancer is to learn more about the safety of ramucirumab when given by injection under the skin (subcutaneous injection).
How long will I be in the trial?
Your participation in this trial could last up to 24 months, depending on your cancer type and how you and your tumor respond.
Not yet recruiting
A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer
I4T-MC-JVDU - ClinicalTrials.gov - NCT04557384
The purpose of this study in participants with advanced cancer is to learn more about the safety of ramucirumab when given by injection under the skin (subcutaneous injection).
How long will I be in the trial?
Your participation in this trial could last up to 24 months, depending on your cancer type and how you and your tumor respond.
Key Requirements
Age :
18+
Sex:
All
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have a solid tumor
Participants must have stopped all cancer treatment
Participants must have acceptable blood, liver, and kidney functions and electrolytes
Participants must agree to use adequate contraception if sexually active and could cause pregnancy or get pregnant
Participants must NOT
Participants must not have high blood pressure
Participants must not have a bleeding disorder
Participants must not have had a serious heart problem within 6 months of starting the study
Participants must not have cancer that has spread to the brain and causing symptoms
Participants must not have an active infection
Participants must not have a wound that has not healed, ulcer or broken bone within 4 weeks of starting the study
Trial Summary
Conditions the trial is for
Advanced Cancer
What the trial is testing?
Ramucirumab
Could I receive a Placebo?
no
Enrollment Goal
24
Trial Dates
February 2021 - December 2022
Trial Phase
1
Enter your postal code to find the nearest site
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Age
18+
Sex
All
Participants must
Participants must have a solid tumor
Participants must have stopped all cancer treatment
Participants must have acceptable blood, liver, and kidney functions and electrolytes
Participants must agree to use adequate contraception if sexually active and could cause pregnancy or get pregnant
Participants must NOT
Participants must not have high blood pressure
Participants must not have a bleeding disorder
Participants must not have had a serious heart problem within 6 months of starting the study
Participants must not have cancer that has spread to the brain and causing symptoms
Participants must not have an active infection
Participants must not have a wound that has not healed, ulcer or broken bone within 4 weeks of starting the study
Trial Summary
Conditions the trial is for
Advanced Cancer
What the trial is testing?
Ramucirumab
Could I receive a Placebo?
no
Enrollment Goal
24
Trial Dates
February 2021 - December 2022
Trial Phase
1
Not the right fit? Sign up to receive updates on new trials.
Trial Locations
Hide locations not currently recruiting
Enter your postal code to see sites near you
Advanced Cancer Resources
